A glucose meter (or glucometer ) is a medical device for determining the approximate concentration of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking the skin with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in mg/dl or mmol/l.
Since approximately 1980, a primary goal of the management of type 1 diabetes and type 2 diabetes mellitus has been achieving closer-to-normal levels of glucose in the blood for as much of the time as possible, guided by HBGM several times a day. The benefits include a reduction in the occurrence rate and severity of long-term complications from hyperglycemia as well as a reduction in the short-term, potentially life-threatening complications of hypoglycemia.
There are several key characteristics of glucose meters which may differ from model to model:
You can get those for free at free websites.
The cost of home blood glucose monitoring is substantial due to the cost of the test strips. In 2006, the consumer cost of each glucose strip ranged from about $0.35 to $1.00. Manufacturers often provide meters at no cost to induce use of the profitable test strips. Type 1 diabetics may test as often as 4 to 10 times a day due to the dynamics of insulin adjustment, whereas type 2 typically test less frequently, especially when insulin is not part of treatment.
Some batches of counterfeit test strips for some meters have been identified, and these have been shown to produce inaccurate results.. They should not be used and should be reported to the supposed manufacturer.
Accuracy of glucose meters is a common topic of clinical concern. Blood glucose meters must meet accuracy standards set by the International Organization for Standardization (ISO). According to ISO 15197 Blood glucose meters must provide results that are within 20% of a laboratory standard 95% of the time (for concentrations about 75mg/dL, absolute levels are used for lower concentrations). However, a variety of factors can affect the accuracy of a test. Factors affecting accuracy of various meters include calibration of meter, ambient temperature, pressure use to wipe off strip (if applicable), size and quality of blood sample, high levels of certain substances (such as ascorbic acid) in blood, hematocrit, dirt on meter, humidity, and aging of test strips. Models vary in their susceptibility to these factors and in their ability to prevent or warn of inaccurate results with error messages. The Clarke Error Grid has been a common way of analyzing and displaying accuracy of readings related to management consequences. More recently an improved version of the Clarke Error Grid has come into use: It is known as the Consensus Error Grid.
In 1962, Clark and Lyons at the Cincinnati Children's Hospital developed the first glucose enzyme electrode. It relied on a thin layer of glucose oxidase on an oxygen electrode. The sensor worked by measuring the amount of oxygen consumed by the enzyme.
Another early glucose meter was the Ames Reflectance Meter by Anton H. Clemens. It was used in American hospitals in the 1970s. It was about 10 inches long. It needed connection to an electrical outlet for power. A moving needle indicated the blood glucose after about a minute.
Home glucose monitoring was demonstrated to improve glycemic control of type 1 diabetes in the late 1970s, and the first meters were marketed for home use around 1980. The two models initially dominant in North America in the 1980s were the Glucometer whose trademark is owned by Bayer and the Accu-chek meter (by Roche). Consequently, these brand names have become synonymous with the generic product to many health care professionals. In Britain, a health care professional or a patient may refer to "taking a BM": "Mrs X's BM is 5", etc. BM stands for Boehringer Mannheim, now called Roche, who produced test strips called 'BM-test'.
Test strips that changed color and could be read visually, without a meter, were also widely used in the 1980s. They had the added advantage that they could be cut longitudinally to save money. As meter accuracy and insurance coverage improved, they lost popularity. However, a generic version of the BM is marketed under the brand name Glucoflex-R. There is a UK Pharmaceutical company (Ambe Medical Group) who have the executive rights for distribution within the United Kingdom. Another visual strip is also marketed under the brand name Betachek.
At least in North America, hospitals resisted adoption of meter glucose measurements for inpatient diabetes care for over a decade. Managers of laboratories argued that the superior accuracy of a laboratory glucose measurement outweighed the advantage of immediate availability and made meter glucose measurements unacceptable for inpatient diabetes management. Patients with diabetes and their endocrinologists eventually persuaded acceptance. Some health care policymakers still resist the idea that the society would be well advised to pay the consumables (reagents, lancets, etc.) needed.
Home glucose testing was adopted for type 2 diabetes more slowly than for type 1, and a large proportion of people with type 2 diabetes have never been instructed in home glucose testing. This has mainly come about because health authorities are reluctant to bear the cost of the test strips and lancets.
Development of noninvasive devices may enable continuous monitoring. Research is being done on noninvasive methods for measuring blood glucose, such as using infrared or near-infrared light, electric currents, and ultrasound.
One noninvasive glucose meter has been approved by the U.S. FDA: The GlucoWatch G2 Biographer is designed to be worn on the wrist and uses electric fields to draw out body fluid for testing. The device does not replace conventional blood glucose monitoring. One limitation is that the GlucoWatch is not able to cope with perspiration at the measurement site. Sweat must be allowed to dry before measurement can resume. Due to this limitations and others, the product is no longer on the market.
The market introduction of noninvasive blood glucose measurement by spectroscopic measurement methods, in the field of near-infrared (NIR), by extracorporal measuring devices, faile
We offer quality diabetic glucose test strips such as the FreeStyle test strips, Accu-Chek test strips and diabetes test strips from many other quality brands for an accurate ...
Two new studies published in this week's issue of the Canadian Medical Association Journal suggest that the costs of diabetes test strips outweigh the benefits of glucose ...
Arctic have many years of experience within the Blood Glucose Monitoring market.
Wholesale discount prices on brand name glucose test strips including Accu Chek, FreeStyle and Ascensia.
The Diabetes Mall offers a full line of blood glucose test strips at low prices, including OneTouch Ultra, Therasense Freestyle, Bayer Ascensia, Hypoguard Advance and Roche Accu ...
Cheap Diabetes Test Strips is an online store that offers low prices on glucose test strips like one touch ultra
149 cost of bg test strips CANADIAN JOURNAL OF DIABETES. 2003;27(2):149-153. The cost of blood glucose (BG) test strips for self-monitoring of blood glucose (SMBG) is of relevance, as ...
Dear Doctor. Re: Availability of blood glucose test strips for people with Type 1 and Type 2 diabetes. This letter follows contact with Diabetes UK from one of your patients who ...
Items in your Cart: 0 . Current Subtotal: $0.00
Cheap Diabetes Medical Supply offers a wide variety of glucose or diabetes test strips and glucometer. we offer Accu-Check, Freestyle, Precision, Ascensia, and One Touch test strips